Minerva Financial Statements From 2010 to 2026

Stocks . USA . 
Stock . Minerva Neurosciences
NERV Stock  USD 3.92  0.10  2.49%   
Minerva Neurosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Minerva Neurosciences' valuation are provided below:
Gross Profit
-5.6 M
Market Capitalization
26.9 M
Enterprise Value Revenue
0.0345
Earnings Share
(1.85)
There are over one hundred nineteen available fundamental ratios for Minerva Neurosciences, which can be analyzed over time and compared to other ratios. All traders should should check Minerva Neurosciences' last-minute fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable.
Check Minerva Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Minerva Neurosciences' main balance sheet or income statement drivers, such as Other Operating Expenses of 34.6 M, Research Development of 23.6 M or EBITDA of 5.7 M, as well as many indicators such as Price To Sales Ratio of 1.86, Dividend Yield of 0.0 or Days Sales Outstanding of 0.0. Minerva financial statements analysis is a perfect complement when working with Minerva Neurosciences Valuation or Volatility modules.
  
Build AI portfolio with Minerva Stock
Check out the analysis of Minerva Neurosciences Correlation against competitors.
For more information on how to buy Minerva Stock please use our How to Invest in Minerva Neurosciences guide.

Minerva Neurosciences Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Common Stock Shares Outstanding4.7 M8.7 M4.5 M
Slightly volatile
Total Assets84.4 M42.7 M66.2 M
Pretty Stable
Other Current Liabilities1.4 M1.1 M1.5 M
Pretty Stable
Total Current Liabilities3.1 M2.6 M3.3 M
Pretty Stable
Cash33.8 M24.6 M27 M
Slightly volatile
Cash And Short Term Investments23.3 M24.6 M37.1 M
Pretty Stable
Common Stock Total Equity3 K4.9 K3 K
Slightly volatile
Liabilities And Stockholders Equity84.4 M42.7 M66.2 M
Pretty Stable
Other Current Assets1.5 M1 M1.2 M
Slightly volatile
Other Stockholder Equity275.4 M425.1 M234.4 M
Slightly volatile
Total Liabilities44.7 M72.3 M38 M
Slightly volatile
Total Current Assets50.7 M25.6 M39.8 M
Slightly volatile
Common Stock5986291.7 K
Very volatile
Short and Long Term Debt Total72.5 M69 M27.3 M
Slightly volatile
Property Plant And Equipment Net5.9 K6.3 K38.4 K
Very volatile
Current Deferred Revenue34 B47.4 B31.4 B
Slightly volatile
Accounts Payable1.5 M1.8 M1.3 M
Slightly volatile
Non Current Assets Total26.5 M13.4 M30.6 M
Slightly volatile
Other Assets0.860.912 M
Pretty Stable
Good Will15.7 M17.1 M13.4 M
Slightly volatile
Non Current Liabilities Total43.8 M69 M36.1 M
Slightly volatile
Short Term Debt121.5 K127.9 K2.4 B
Very volatile
Intangible Assets17.9 B17.1 B3 B
Slightly volatile
Property Plant Equipment36.8 K18.8 K24.4 K
Slightly volatile
Other Liabilities89 M84.8 M36.7 M
Slightly volatile
Capital Surpluse278.9 M388.1 M252.7 M
Slightly volatile
Deferred Long Term Liabilities1.5 M1.6 M10.5 M
Slightly volatile
Short and Long Term Debt3.2 M4.6 M3.1 M
Slightly volatile
Long Term Debt Total4.9 M3.5 M5.5 M
Slightly volatile
Net Working Capital16.6 M17.5 M77.8 M
Slightly volatile
Capital Stock5986293 K
Slightly volatile
Net Receivables2.5 M2.8 M3.1 M
Slightly volatile

Minerva Neurosciences Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Other Operating Expenses34.6 M25.1 M29.5 M
Slightly volatile
Research Development23.6 M13.7 M19.9 M
Slightly volatile
Total Operating Expenses34.6 M25.1 M29.5 M
Slightly volatile
Depreciation And Amortization50.7 K25.8 K39.8 K
Slightly volatile
Selling General Administrative11.8 M11.4 M9.7 M
Slightly volatile
Non Operating Income Net Other102.7 K108.1 K294.8 K
Very volatile
Interest Income788.1 K1.3 M957.4 K
Very volatile
Reconciled Depreciation19.2 K20.2 K38 K
Pretty Stable
Extraordinary Items7.5 M8.5 M9.2 M
Slightly volatile
Selling And Marketing Expenses8.1 B8.9 B10.2 B
Slightly volatile

Minerva Neurosciences Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation1.1 M1.2 M4.3 M
Very volatile
Begin Period Cash Flow32.1 M47.2 M27 M
Slightly volatile
End Period Cash Flow33.9 M24.7 M27 M
Slightly volatile
Depreciation24.5 K25.8 K46.1 K
Very volatile

Financial Ratios

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio1.862.092.2794
Slightly volatile
Average Payables905.1 K1.2 M1.1 M
Slightly volatile
Stock Based Compensation To Revenue0.190.210.2315
Slightly volatile
Capex To Depreciation2.131.732.2463
Very volatile
EV To Sales1.371.541.6772
Slightly volatile
Payables Turnover0.01190.01260.0275
Pretty Stable
Sales General And Administrative To Revenue0.340.380.4128
Slightly volatile
Research And Ddevelopement To Revenue0.430.480.5258
Slightly volatile
Cash Per Share3.13.267.9114
Very volatile
Days Payables Outstanding26.5 K30 K27.3 K
Pretty Stable
Intangibles To Total Assets0.480.460.5274
Slightly volatile
Current Ratio9.497.0610.1721
Slightly volatile
Capex Per Share0.00330.00350.0051
Pretty Stable
Revenue Per Share6.467.267.9267
Slightly volatile
Interest Debt Per Share8.067.683.7019
Slightly volatile
Debt To Assets1.531.450.5329
Slightly volatile
Graham Number7.528.469.2322
Slightly volatile
Days Of Payables Outstanding26.5 K30 K27.3 K
Pretty Stable
Pretax Profit Margin0.03770.04240.0463
Slightly volatile
Operating Profit Margin0.03590.04040.0441
Slightly volatile
Long Term Debt To Capitalization1.451.380.8802
Slightly volatile
Ebit Per Revenue0.03590.04040.0441
Slightly volatile
Quick Ratio9.627.0610.3086
Slightly volatile
Net Income Per E B T0.720.870.8542
Slightly volatile
Cash Ratio7.16.787.7283
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.11.151.0123
Slightly volatile
Fixed Asset Turnover324364397
Slightly volatile
Debt Ratio1.531.450.5329
Slightly volatile
Price Sales Ratio1.862.092.2794
Slightly volatile
Asset Turnover0.570.640.7016
Slightly volatile
Net Profit Margin0.03770.04240.0463
Slightly volatile

Minerva Neurosciences Valuation Data

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Market Cap87.3 M98.2 M107.2 M
Slightly volatile
Enterprise Value72.5 M81.5 M89 M
Slightly volatile

Minerva Fundamental Market Drivers

Forward Price Earnings11.2108
Cash And Short Term Investments21.4 M

Minerva Upcoming Events

13th of March 2024
Upcoming Quarterly Report
View
20th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Minerva Neurosciences Financial Statements

Minerva Neurosciences investors use historical fundamental indicators, such as Minerva Neurosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Minerva Neurosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue47.4 B34 B
Cost Of Revenue25.8 K24.5 K
Stock Based Compensation To Revenue 0.21  0.19 
Sales General And Administrative To Revenue 0.38  0.34 
Research And Ddevelopement To Revenue 0.48  0.43 
Revenue Per Share 7.26  6.46 
Ebit Per Revenue 0.04  0.04 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Minerva Stock Analysis

When running Minerva Neurosciences' price analysis, check to measure Minerva Neurosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Minerva Neurosciences is operating at the current time. Most of Minerva Neurosciences' value examination focuses on studying past and present price action to predict the probability of Minerva Neurosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Minerva Neurosciences' price. Additionally, you may evaluate how the addition of Minerva Neurosciences to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY